Expert Advisors

LI FengLI Feng owns Ph.D degree of Chemical Engineering from Rice University, Master’s degree of Chemistry from Tsinghua University and Bachlor’s degree of Biological Engineering from Shanghai Jiaotong University.
LI Feng worked as the chief engineer at Genentech, senior scientist at Amgen, engineering at Tanox. Throughout his working experiences, he contributed to a series of discoveries of monoclonal drugs. He holds two U.S patents and has published over 20 academic articles. He established a core team devoted to developing antibody-based drugs when he returned China in 2011. Experienced in drug research and design, LI Feng provides technical support for Mefund.
LI Feng
HUANG XuHUANG Xu is a post-doctor from Harvard Medical School and received his Ph.D degree from University of South Carolina.
HUANG Xu worked as a researcher at Peking Union Medical College Hospital, assessor at Massachusetts public healthcare institute, vice president of Sino Biological Inc. He is very veteran in the field of drug design, clinical studies as well project assessment. HUANG Xu manages over ten drug design projects and over twenty clinical reagents projects. As an expert consultant, HUANG Xu provides his opinions on healthcare investments for Mefund Capital.